Literature DB >> 2657410

Overcoming pharmacokinetic problems in the treatment of Parkinson's disease.

J A Obeso1, J Vaamonde, F Grandas, M R Luquin, M Rodriguez, G Lera, J M Martínez-Lage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2657410     DOI： 10.1002/mds.870040510

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  3 in total

1.  Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson's disease.

Authors:  Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

Review 2.  Current status of dopamine agonists in Parkinson's disease management.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

3.  Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation.

Authors:  Harsh V Gupta; Vibhash D Sharma
Journal:  Mov Disord Clin Pract       Date:  2021-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.